Ancient viral DNA in our cells fuels inflammation with age
Every human cell contains ancient stretches of DNA that originated from viruses. In youth, they are kept silent. As we age, that silence breaks down and they begin generating a constant low-grade inflammation. Researchers now think this process contributes to cancer, dementia, and other diseases of aging.
These sequences are called transposable elements, sometimes informally called jumping genes. They can copy themselves and insert into other parts of the genome. In young organisms, they are kept under tight epigenetic control, meaning the cellular machinery that regulates which genes are accessible keeps them switched off. That control weakens with age.
When transposable elements become active, they produce virus-like particles. The immune system recognises these as foreign and mounts a response. The outcome is a chronic, sterile inflammation with no actual infection present. Researchers link this to the persistent low-grade inflammation characteristic of aging, known as inflammaging.
Two strategies from the same mechanism
A review published in EMBO Molecular Medicine outlines two opposing therapeutic strategies. On one side, transposable element activity can be suppressed using existing drugs, including nucleoside reverse transcriptase inhibitors. These block the copying process and may dampen inflammation. On the other side, the researchers describe how controlled activation of transposable elements in tumour cells can make those cells more vulnerable to immune checkpoint therapies.
The same virus-like particles that cause harm in healthy aging tissue can provoke a useful immune attack when triggered inside cancer cells. The mechanism is identical; the desired outcome depends entirely on context.
Promising but early
Therapeutic applications remain largely in the research phase. Nucleoside reverse transcriptase inhibitors are already approved drugs, originally developed for HIV. Whether they effectively reduce aging-related inflammation in humans must still be demonstrated in randomised trials. This review argues that transposable elements should no longer be seen as passive genomic junk, but as an active and potentially manageable part of aging and disease.
Search terms to explore further: transposable elements epigenetic silencing aging | inflammaging sterile inflammation | reverse transcriptase inhibitor senescence